title: Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA.
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Mellati
authors.affiliation: Division of Medical Oncology, University of Washington, Seattle, WA.
authors.forename: Keith D
authors.initials: KD
authors.lastname: Eaton
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Division of Endocrinology, VA Puget Sound Health Care System, Seattle, WA.
authors.forename: Barbara M
authors.initials: BM
authors.lastname: Brooks-Worrell
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Pacific Northwest Diabetes Research Institute, Seattle, WA.
authors.forename: William A
authors.initials: WA
authors.lastname: Hagopian
authors.affiliation: Division of Medical Oncology, University of Washington, Seattle, WA.
authors.forename: Renato
authors.initials: R
authors.lastname: Martins
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Division of Endocrinology, VA Puget Sound Health Care System, Seattle, WA.
authors.forename: Jerry P
authors.initials: JP
authors.lastname: Palmer
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA ihirsch@uw.edu.
authors.forename: Irl B
authors.initials: IB
authors.lastname: Hirsch
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology; D000077192:Adenocarcinoma of Lung; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology* / Q000276:immunology; D016883:Diabetic Ketoacidosis / Q000139:chemically induced / Q000276:immunology; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007573:Jaw Neoplasms / Q000188:drug therapy / Q000276:immunology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology; D008297:Male; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000911:Antibodies, Monoclonal; D060890:B7-H1 Antigen; C423236:CD274 protein, human; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor